Seres Therapeutics(MCRB)

1.32 -0.04 -2.9412%

今开:1.39昨收:1.36
最高:1.4299 最低:1.29
涨停价:0.0跌停价:0.0
总市值:1.99911047E8

Seres Therapeutics的热门讨论

学习滚雪球07-17 22:53

$Seres Therapeutics(MCRB)$ 走势这么猛啊翔哥。。。查看全文

持股变动声明

Seres Therapeutics(MCRB)07-04 04:25

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081522  Size: 5 KB 网页链接查看全文

季度财报

Seres Therapeutics(MCRB)05-08 22:05

$Seres Therapeutics(MCRB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055159  Act: 34  Size: 10 MB 网页链接查看全文

学习滚雪球05-08 22:01

$Seres Therapeutics(MCRB)$ 第二个完整季度还是只卖出500份。。。前半个月的走势是赌财报呢?查看全文

持股变动声明

Seres Therapeutics(MCRB)05-18 08:25

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062061  Size: 9 KB 网页链接查看全文

持股变动声明

Seres Therapeutics(MCRB)05-18 08:25

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062052  Size: 9 KB 网页链接查看全文

美股滚雪球06-10 12:07

$Seres Therapeutics(MCRB)$ 宣布,已达成一项非约束性协议,将其fda批准的微生物组疗法Vowst和相关知识产权出售给消费者护理巨头雀巢(OTCPK:NSRGY) (OTCPK:NSRGF)的子公司雀巢健康科学。
Vowst由Seres (MCRB)与雀巢健康科学(nestle Health Science)合作开发,于2023年获得FDA批准,成为首个用...查看全文

当期报告

Seres Therapeutics(MCRB)05-08 19:15

$Seres Therapeutics(MCRB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-133766  Act: 34  Size: 240 KB 网页链接查看全文

持股变动声明

Seres Therapeutics(MCRB)05-18 08:25

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062058  Size: 9 KB 网页链接查看全文

持股变动声明

Seres Therapeutics(MCRB)05-18 08:25

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062057  Size: 9 KB 网页链接查看全文

1 2

Seres Therapeutics的最新讨论

JZee2023-04-27 14:10

$赛里斯治疗(MCRB)$ 的口服翔获批了,用于治疗复发的艰难梭菌感染。美国每年复发艰难梭菌感染人数约十五万,看高一点算20%渗透。定价目前还没出来,和辉凌的非口服的翔做个比较的话,大概定价五千到一万美元还是可以的。粗算能卖两三亿美元?接着看竞争形态。竞品1,$辉瑞(PFE)$ 的艰难梭菌疫苗,...查看全文

joe88772023-04-27 08:19

$赛里斯治疗(MCRB)$ Seres Therapeutics and Nestl Health Science Announce FDA Approval of VOWSTTM (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI查看全文

牛唐2023-04-25 21:53

医药板块速评(2023.04.22)
1、$In8bio(INAB)翻倍,谁有潜力成为下一个?
2、$赛里斯治疗(MCRB)$ 上市审批在即,是否有配置机会?
3、$蔚来-SW(09866)$$Coinbase Global(COIN)$ 、$雾芯科技(RLX)、$VMware(VMW)、$斯普林特(S)期权异动,后续走势如何看?查看全文

JZee2022-10-28 11:48

$赛里斯治疗(MCRB)$ ,从此治疗艰难梭菌感染不用再吃屎啦[很赞]查看全文

JZee2022-06-20 11:24

$赛里斯治疗(MCRB)$是做肠道菌群药物的,宣传词很响亮:“赛里斯疗法胜过益生菌,以及粪便移植疗法。”查看全文

jincen02082022-05-27 07:15

#生物医药科技笔记##医药创新#
2022年5月26日 Flagship以7500万美元投资孵化出ProFound Therapeutics公司,将探索一批新蛋白靶点;
1、Flagship Pioneering是一家著名生物医疗风投机构以及初创企业孵化器,其中孵化了包括Moderna、Seres Therapeutics、Rubius等知名公司,其中Moderna因疫...查看全文

joe88772022-01-20 16:08

$赛里斯治疗(MCRB)$ New England Journal of Medicine Publishes Data from ECOSPOR lll Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection查看全文

1 2 3 4 5 6 7 8

Seres Therapeutics的公告

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081521  Size: 5 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081522  Size: 5 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081527  Size: 5 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062052  Size: 9 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062056  Size: 9 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062059  Size: 9 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062057  Size: 9 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062058  Size: 9 KB 网页链接

持股变动声明

$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062061  Size: 9 KB 网页链接

季度财报

$Seres Therapeutics(MCRB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055159  Act: 34  Size: 10 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46